[HTML][HTML] Novel treatments for anaplastic thyroid carcinoma

SM Ferrari, G Elia, F Ragusa, I Ruffilli, C La Motta… - Gland …, 2020 - ncbi.nlm.nih.gov
Anaplastic thyroid cancer (ATC) is one of the deadliest human cancers and it is less than 2%
of thyroid carcinomas (TCs). The standard treatment of ATC includes surgical debulking …

Application of immunohistochemistry in thyroid pathology

H Liu, F Lin - Archives of Pathology and Laboratory …, 2015 - meridian.allenpress.com
Context Accurate classification of follicular-patterned thyroid lesions is not always an easy
task on routine surgical hematoxylin-eosin–stained or cytologic fine-needle aspiration …

Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: a new quantitative method for improving diagnostic accuracy

A Campennì, M Siracusa, RM Ruggeri, R Laudicella… - Scientific reports, 2017 - nature.com
Quantitative 99mTc-MIBI thyroid scintigraphy is a useful tool in differentiating malignant from
benign thyroid nodules with indeterminate cytology. The aim of our report is to compare the …

Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures

A Mohamed, MP Blanchard, M Albertelli… - Endocrine-related …, 2014 - erc.bioscientifica.com
The HER2 transmembrane receptor is a well-characterised predictive marker for
trastuzumab benefit and may be associated with decreased benefit from endocrine therapy …

MiRNA let-7 from TPO (+) extracellular vesicles is a potential marker for a differential diagnosis of follicular thyroid nodules

L Zabegina, I Nazarova, M Knyazeva, N Nikiforova… - Cells, 2020 - mdpi.com
Background: The current approaches to distinguish follicular adenomas (FA) and follicular
thyroid cancer (FTC) at the pre-operative stage have low predictive value. Liquid biopsy …

DNA methylation in thyroid tumorigenesis

JK Stephen, D Chitale, V Narra, KM Chen, R Sawhney… - Cancers, 2011 - mdpi.com
Thyroid cancer is the most common endocrine cancer with 1,690 deaths each year. There
are four main types of which the papillary and follicular types together account for> 90 …

Methylation markers differentiate thyroid cancer from benign nodules

JK Stephen, KM Chen, J Merritt, D Chitale… - Journal of …, 2018 - Springer
Purpose The incidence of thyroid cancer (TC) is increasing. Cytology by itself cannot
distinguish TC from some benign nodules especially in certain subtypes of TC. Our …

Anaplastic thyroid carcinoma: current treatments and potential new therapeutic options with emphasis on TfR1/CD71

R Parenti, L Salvatorelli, G Magro - International journal of …, 2014 - Wiley Online Library
Anaplastic thyroid carcinoma (ATC) is one of the most aggressive human cancers. Actually,
ATC is refractory to conventional therapies, including surgery, chemotherapy, radiotherapy …

Nanostructures: Between natural environment and medical practice

MC Trovato, D Andronico, S Sciacchitano… - Reviews on …, 2018 - degruyter.com
Nanoparticles (NPs) are small structures under 100 nm in dimension. Interrelationships
among the morphological parameters and toxicity of NPs have been the focus of several …

Urokinase plasminogen activator and its inhibitor type-1 as prognostic factors in differentiated thyroid carcinoma patients

G Horvatic Herceg, D Herceg, M Kralik… - … --Head and Neck …, 2013 - journals.sagepub.com
Objective To investigate the prognostic value of urokinase-type plasminogen activator (uPA)
and its inhibitor, type-1 plasminogen activator inhibitor (PAI-1), in differentiated thyroid …